Skip to main content
| News

Clinerion is now part of Citeline

02.02.2023

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with regard to drug development acceleration. Clinerion’s headquarters are to remain in Basel.

Clinerion’s CEO Barış Erdoğan has officially announced that the company is now part of Citeline, a leader in clinical trials. The company based in New York, which formerly operated as Pharma Intelligence, merged with Norstella from the US state of Pennsylvania at the end of 2022. This means that the Norstella Group now comprises five companies: Evaluate, MMIT, Panalgo, The Dedham Group, and Citeline.

The new pharmaceutical technology company with more than 1,600 employees across the world is now one of the world’s largest providers of pharma information solutions on the market. According to a press release from Norstella, it is currently valued at 5 billion US dollars. It aims to enable smooth access to life-saving therapies for those with illnesses by accompanying life science companies throughout the entire drug development process.

Clinerion’s headquarters remain in Basel

According to a personal message from Clinerion’s CEO, its integration into Citeline provides the opportunity to access tools and services that each supplement the other’s, thus expanding the product portfolio. Furthermore, Clinerion will gain access to specialists and expertise along the entire process chain from clinical intelligence, planning, development, and studies. This is why the merger with Citeline and the Norstella Group is “excellent news” for partners and customers. Clinerion’s headquarters will remain in Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Sustainability

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...

Read More
Noema Pharma raises 103 million Swiss francs from investors
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Read More
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Why CDMO companies choose the Basel Area as their location

Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

Read More
1 2 3 61

Do you have a question? We'd like to hear from you.